Table 1 Baseline and angiographic characteristics
All patients | Pts MVOneg | Pts MVOpos | P | |
|---|---|---|---|---|
N = 51 | N = 22 (43%) | N = 29 (57%) | ||
Age - years | 53.6 ± 9.9 | 56 ± 10 | 52.6 ± 9.4 | 0.27 |
Female (%) | 9 (18) | 4 (19) | 5 (17.5) | 0.93 |
Arterial hypertension (%) | 18 (35) | 7 (32) | 11(38) | 0.65 |
Diabetes mellitus (%) | 11 (22) | 5 (23) | 6 (21) | 0.86 |
Family history of CAD (%) | 15 (29) | 7 (32) | 8 (27) | 0.74 |
Current smoking | 42 (82) | 18 (82) | 24 (83) | 0.93 |
Hyperlipidemia (%) | 21 (41) | 9 (41) | 12 (41) | 0.97 |
Body mass index ≥30Kg/m 2 (%) | 9 (18) | 3 (14) | 6 (20.6) | 0.51 |
One vessel disease (%) | 28 (55) | 13 (59) | 15 (52) | 0.60 |
Multivessel disease (%) | 16 (31) | 7 (32) | 9 (31) | 0.95 |
Stenosis < 50% (%) | 7 (14) | 2 (9) | 5 (17) | 0.40 |
Anterior location (%) | 18 (35) | 9 (41) | 9 (31) | 0.46 |
Time from symptom onset to 1 st reperfusion therapy – hours | 5.3 ± 3.2 | 4.7 ± 2.9 | 5.9 ± 3.7 | 0.21 |
Fibrinolysis (%) | 14 (27) | 5 (23) | 9 (31) | 0.73 |
Primary PCI (%) | 37 (73) | 17 (77) | 20 (69) | |
Rescue PCI (%) | 6 (12) | 2 (9) | 4 (14) | 0.94 |
Aspirin | 51 (100) | 22 (100) | 29 (100) | 1 |
Clopidogrel loading dose (300/600 mg) | 34/17 | 14/8 | 20/9 | 0.69 |
GP IIb-IIIa inhibitors (%) | 22 (43) | 8 (36) | 14(48) | 0.39 |
TnI peak (ng/mL) (range) | 81 ± 71 | 53.6 (13–225) | 118.5 (22–585) | 0.0006 |
CK peak, U/L (range) | 1985 ± 1522 | 1825 (63–9580) | 2663 (160–9930) | 0.006 |
CK-MB peak, U/L (range) | 124 ± 132 | 145.6 (9–940) | 189.1 (9–760) | 0.09 |